Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Oncotargets and Therapy|October 28, 2022
A Case of Hepatocellular Carcinoma Successfully Resumed Atezolizumab and Bevacizumab After Associated Grade 3 Diarrhea and Grade 2 Colitis: Case Report and Literature ReviewTakahiro Fuji, Jun Arai, Yumi Otoyama, et al.
Cancer Immunology, Immunotherapy : CII|July 20, 2020
Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA sheddingJun Arai, Kaku Goto, Yumi Otoyama, et al.
Anticancer Research|May 6, 2021
Retinoids Decrease Soluble MICA Concentration by Inhibiting the Enzymatic Activity of ADAM9 and ADAM10Yumi Otoyama, Jun Arai, Kaku Goto, et al.
Health Science Reports|July 21, 2020
Decreased expression of interferon-stimulated genes in B cells of patients with chronic hepatitis C during interferon-free therapy potentially suggests the eradication of hepatitis C virus in the B cells: A cohort studyJun Arai, Takayoshi Ito, Yuu Shimozuma, et al.
Clinical Pharmacokinetics|June 23, 2026
ALBI Grade is a Determinant of Lenvatinib Pharmacokinetics, Efficacy, and Toxicities in Japanese Patients with Hepatocellular CarcinomaKosuke Suzuki, Yumi Otoyama, Natsumi Matsumoto, et al.
BMC Gastroenterology|November 16, 2019
Three cases of histologically proven hepatic epithelioid hemangioendothelioma evaluated using a second-generation microbubble contrast medium in ultrasonography: case reportsJun Arai, Yuu Shimozuma, Yumi Otoyama, et al.
In Vivo (Athens, Greece)|July 2, 2020
Laparoscopic Treatment of a Hepatoduodenal Ligament Schwannoma With Infrared Indocyanine Green FluorescenceKodai Tomioka, Takeshi Aoki, Tomotake Koizumi, et al.
Pageof 2